Atlas Trials

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

Clinical trial NCT01892644 · WITHDRAWN

Trial details

NCT number
NCT01892644
Sponsor
Haukeland University Hospital
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
HemochromatosisMyelodysplastic Syndromes
Start date
2013-05-01
Primary completion
2017-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.